US Real-World Effectiveness Study of Nirmatrelvir/Ritonavir in Preventing Hospitalization of High-Risk COVID-19 Patients by Mark R. Cullen, MD, Xiaofeng Zhou, PhD, Scott P. Kelly, PhD, Caihua Liang, MD, PhD, Ling Li, MS, Rongjun Shen, MS, Heidi K. Leister-Tebbe, BSN, Steven G. Terra, PharmD, Michael Gaffney, PhD, Leo Russo, PhD

Get full text